Multicentre medicoeconomic evaluation of cardiac magnetic resonance imaging for predicting coronary artery disease in left ventricular dysfunction: The CAMAREC study design

Mosterd, 1999, Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study, Eur Heart J, 20, 447, 10.1053/euhj.1998.1239 van Riet, 2016, Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review, Eur J Heart Fail, 18, 242, 10.1002/ejhf.483 Assomull, 2011, Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology, Circulation, 124, 1351, 10.1161/CIRCULATIONAHA.110.011346 McCrohon, 2003, Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance, Circulation, 108, 54, 10.1161/01.CIR.0000078641.19365.4C Schietinger, 2007, Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure?, Int J Cardiovasc Imaging, 23, 595, 10.1007/s10554-006-9200-x Soriano, 2007, Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience, Int J Cardiol, 116, 167, 10.1016/j.ijcard.2006.03.040 Valle-Munoz, 2009, Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure, Eur J Echocardiogr, 10, 968, 10.1093/ejechocard/jep115 Casolo, 2006, Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement, Am Heart J, 151, 101, 10.1016/j.ahj.2005.03.068 le Polain de Waroux, 2008, Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging, Eur Heart J, 29, 2544, 10.1093/eurheartj/ehn381 Soriano, 2005, Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance, J Am Coll Cardiol, 45, 743, 10.1016/j.jacc.2004.11.037 Desroche, 2020, Cardiovascular magnetic resonance may avoid unnecessary coronary angiography in patients with unexplained left ventricular systolic dysfunction: a Retrospective Diagnostic Pilot Study, J Card Fail, 26, 1067, 10.1016/j.cardfail.2020.09.005 Cowie, 2015, Adaptive servo-ventilation for central sleep apnea in systolic heart failure, N Engl J Med, 373, 1095, 10.1056/NEJMoa1506459 McMurray, 2012, Eur J Heart Fail, 14, 803, 10.1093/eurjhf/hfs033 Taylor, 2004, Combination of isosorbide dinitrate and hydralazine in blacks with heart failure, N Engl J Med, 351, 2049, 10.1056/NEJMoa042934 Windecker, 2014, Eur Heart J, 35, 2541, 10.1093/eurheartj/ehu278 Felker, 2002, A standardized definition of ischemic cardiomyopathy for use in clinical research, J Am Coll Cardiol, 39, 210, 10.1016/S0735-1097(01)01738-7 McDonagh, 2021, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 42, 3599, 10.1093/eurheartj/ehab368 Yancy, 2017, ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America, J Am Coll Cardiol, 70, 776, 10.1016/j.jacc.2017.04.025